[Skip to Navigation]
Comment & Response
July 2017

Neuroleptics for Delirium: More Research Is Needed

Author Affiliations
  • 1Department of Palliative Care, Rehabilitation and Integrative Medicine, MD Anderson Cancer Center, Houston, Texas
  • 2Department of Psychiatry, MD Anderson Cancer Center, Houston, Texas
JAMA Intern Med. 2017;177(7):1052-1053. doi:10.1001/jamainternmed.2017.1783

To the Editor We read with interest the Original Investigation in a recent issue of JAMA Internal Medicine by Agar et al1 on the management of delirium in the palliative care setting. Delirium is one of the most common and disturbing syndromes at the end of life,2 and there are few well-designed studies to inform practice.3 Because data from geriatrics and other populations cannot be extrapolated to the palliative care setting, this important study1 provides unique insights into the role of haloperidol and risperidone compared with placebo; however, several issues regarding the study design complicate its interpretation.

Add or change institution